Bausch Health Companies | VRX - Le Bénéfice D'Exploitation

Prix De L'Action
7.48
Variation Quotidienne
-0.28 -3.61%
Mensuellement
-4.35%
Annuel
-6.38%
Q2 Prévisions
6.81




Le Bénéfice D'Exploitation Changement Date
Amgen USD 3.96B 464M 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Bausch Health Companies USD 719M 2M 2025-12
Biogen USD 659.6M 192.2M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Danaher USD 1.5B 348M 2025-12
Drreddys Laboratories INR 14.33B 2.51B 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novo Nordisk DKK 32.38B 1.7B 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Zoetis USD 835M 101M 2025-12